BCLS Acquisition Corp.
BLSA
NASDAQ Capital Market10.04
USD
- -
- -
CIK
0001823200
ISIN
KYG0904B1059
Return %
Stock
S&P500
1Y
1.47
20.11
3Y
-1.42
72.11
5Y
-1.42
70.65
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Jeffrey Lawrence Schwartz
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 200 Clarendon Street Boston MA United States of America 02116
- IPO Date
- Oct 2, 2020
- CIK
- 0001823200
- Website
- bclsacquisitioncorp.com
- Similar Companies
- Business
- BCLS Acquisition Corp. (BLSA) is a blank check company sponsored by an affiliate of Bain Capital Life Sciences whose shares were redeemed and delisted from Nasdaq following its liquidation in October 2022. Formed in 2020 and based in Boston, Massachusetts, the company had no significant operations or revenue; it sought to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, focusing primarily on biopharmaceutical, specialty pharmaceutical, medical device, diagnostics, and enabling life science technology companies in North America and Europe, with selective opportunities in Asia and emerging markets. In October 2022, after failing to complete an initial business combination within the required timeframe, BCLS Acquisition announced the redemption of all its public Class A ordinary shares at approximately the initial offering price, ceasing trading on Nasdaq as of October 26, 2022, cancelling the shares, and winding down operations except for liquidation requirements. The company had priced its $125 million initial public offering in October 2020 at $10 per Class A share, led by Chairman Adam Koppel, CEO Jeffrey Schwartz, and CFO Andrew Hack, with Goldman Sachs and Jefferies as lead underwriters.
Company News
South African reform momentum turns negative, lobby group tracker shows
BCLS Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
BCLS Acquisition Corp. Announces Pricing of $125 Million Initial Public Offering